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Abstract: Silver nanoparticles (AgNPs) are widely used as antibacterial agent and anticancer 35 
drug. However, in many cases the low AgNPs stability limits their massive production and 36 
broad applications. The use of niosomes as carrier, to protect and envelop AgNPs, can solve 37 
these problems. In this study, AgNPs were functionalized with sodium 38 
3-mercapto-1-propanesulfonate (3MPS) to induce high hydrophilic behavior, improving 39 
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their loading in in,Tween 20 and Span 20 niosomes. niosomes. AgNPs were loaded in two 40 
different niosomes, Tween 20 and Span 20, and investigated. Their entrapment efficiency 41 
was evaluated by UV analyses and is around 1-4%. Dimensions were investigated by means 42 
of DLS (<2RH> = 140 ± 4 nm and <2RH> = 251 ± 1 nm respectively for NioTw20+AgNPs 43 
and NioSp20+AgNPs) and the nanosizewere  was confirmedcompared with those by AFM 44 
and SAXS analyses. Moreover, stability was assessed in water up to 90 days, and both in 45 
Bovine Serum (BS) and Human Serum (HS) up to 8 hours. In order to characterize the local 46 
structure of niosomes, SAXS measurements have been performed on Tween20 and Span20 47 
empty niosomes and loaded with AgNPs. The release profiles of hydrophilic probe calcein 48 
and lipophilic probe Nile Red were performed in HHEPESEPES and in human serum. All 49 
these features contribute to deeply define characterize the two systems, NioTw20+AgNPs 50 
and NioSp20+AgNPs, suitable and promising in the field of biological applications. 51 
 52 
Keywords: niosomes; silver nanoparticles; liposomes; plasmonic materials; drug delivery. 53 
 54 
1. Introduction 55 
 56 
It is well known that the body barrier to external pathogenic attacks is represented by the skin, 57 
that prevents microbial invasion [1], so every damage or wound can provide an environment for 58 
microbial growth, leading to infection and prolonged wound healing [2,3]. The efficacy of antibiotics 59 
is superior to that of other drugs, and antibiotics are thus widely used [4,5]. However, the antibiotic 60 
resistance is currently a health emergency so drug-resistant bacterial infections are becoming more 61 
common with a consequent increase in public spending [5]. Therefore, new materials for the 62 
treatment of wound infections are needed [6,7].  63 
Small sizes, nanoparticles have the advantage to be characterized by a larger contact surface 64 
with bacteria, able to enhance their penetration and bactericidal effects [Porcaro, F.; Carlini, L.; 65 
Ugolini, A.; Visaggio, D.; Visca, P.; Fratoddi, I.; Venditti, I.; Meneghini, C.; Simonelli, L.; Marini, C. 66 
Synthesis and structural characterization of silver nanoparticles stabilized with 67 
3-mercapto-1-propansulfonate and 1-thioglucose mixed thiols for antibacterial applications. 68 
Materials 2016, 9, 1028.].[8]. A good candidate is represented by silver nanoparticles (AgNPs) that 69 
show antibacterial properties and reduce inflammatory response [Li, Y. et al Inflammatory 70 
responses to micro/nano-structured titanium surfaces with silver nanoparticles: In vitro; Journal of 71 
Materials Chemistry B Volume 7, Issue 22, 2019, Pages 3546-3559], with no drug resistance in 72 
gram-negative bacteria [Sanyasi S et al. Polysaccharide-capped silver Nanoparticles inhibit biofilm 73 
formation and eliminate multi-drug-resistant bacteria by disrupting bacterial cytoskeleton with 74 
reduced cytotoxicity towards mammalian cells ; Scientific Reports Volume 6, 29 April 2016,  24929].  75 
AgNPs are one of the most used metals in nanotechnology, due to their amazing chemical 76 
physical features. They have a striking anti-microbial activity. In fact, AgNPs are known to cause 77 
oxidative lesion that destroys the bacterial cell wall, due to Ag + ions release, facilitating the entry 78 
into the cell and the disruption of crucial metabolic processes and halts cell proliferation.  79 
Therefore, AgNPs are widely used in several medical devices, such as in coating of bone 80 
prosthesis and chirurgical stents, in orthodontic materials, in bandages [8-11].  81 
Moreover, recently In the last decade, the research field of AgNPs has moved to the possibility 82 
of their use as anticancer drug, due to their inherent cytotoxic effect on cancer cells [12]. 83 
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However, instability of silver nanoparticles limits their industrial application in several cases 84 
and most of the methods to prepare Ag NPs, causing environmental pollution and low production 85 
efficiency. To overcome this problem, silver nanoparticles are usually loaded onto carriers like [13]. 86 
Among various antibacterial agents, silver ions and nanosilver (i.e., Ag nanoparticles (NPs)) 87 
show impressive antimicrobial activity against a broad spectrum of bacteria by destroying infectious 88 
microorganisms, and have an attractive feature of relatively low tendency to cause such bacterial 89 
resistance against antibiotics [2,7]. The bactericidal effect of Ag NPs is mainly attributed to their 90 
small nanoscale sizes and high surface-to-volume ratios, which allow them to relatively quickly 91 
release Ag ions and interact with microbial membranes. Recently, hybrids/composites with Ag NPs 92 
dispersed on carriers or supports have attracted much attention due to their enhanced antibacterial 93 
activity compared with sole Ag NPs [2]. Furthermore, it is of very significance to seek for the optimal 94 
choices of carriers to combine with AgNPs in order to construct ideal antibacterial agents. Various 95 
AgNPs-based nanocomposites with different structures and morphologies have been developed up 96 
to now, such as amorphous silica matrix dispersed with AgNPs [Das.A. et al.; Confinement induced 97 
formation of silver nanoparticles in self-assembled micro-granules Colloids and Surfaces A: 98 
Physicochemical and Engineering Aspects Volume 577, 20 September 2019, Pages 185-193 ], AgNPs 99 
core@silica shell [Huang, J. et al. Unveiling the growth mechanism of SiO 2 /Ag hybrid nanospheres 100 
and using for Surface Enhanced Raman Scattering detection; Applied Surface Science Volume 463, 1 101 
January 2019, Pages 115-120], silica core@silver shell [17e20],mesoporous silicas loaded with Ag NPs 102 
[Mofakham, E.B.  et al.; Progesterone Release from PDMS-Modified Silica Xerogels Containing Ag 103 
Nanoparticles Silicon Volume 11, Issue 2, 15 April 2019, Pages 703-711;   104 
 Arun Kumar, K.V.et al; Surface plasmon response of silver nanoparticles doped silica 105 
synthesised via sol-gel route; Applied Surface Science Volume 472, 1 April 2019, Pages 40-45  ], 106 
hollow mesoporous silica spheres with Ag NPs in cavity [ Lin L. et al; Preparation and antibacterial 107 
activities of hollow silica-Ag spheres;  Colloids and Surfaces B: Biointerfaces Volume 101, 1 January 108 
2013, Pages 97-100 109 
Nishanthi, S.T. et al; Nanostructured silver decorated hollow silica and their application in the 110 
treatment of microbial contaminated water at room temperature; New Journal of Chemistry Volume 111 
43, Issue 23, 2019, Pages 8993-9001 ], fibers coated with Ag NPs [Bonan R.F. et al; In vitro 112 
antimicrobial and anticancer properties of TiO2 blow-spun nanofibers containing silver 113 
nanoparticles;Materials Science and Engineering C Volume 104, November 2019, Article number 114 
109876 115 
Gao A. et al; Efficient antimicrobial silk composites using synergistic effects of violacein and 116 
silver nanoparticles; Materials Science and Engineering C Volume 103, October 2019, Article number 117 
109821],etc.  118 
Although extensive efforts have been devoted to fabricating a lot of these AgNPs-based 119 
nanocomposites involving different carriers' structures, there are still few systematic investigations 120 
on the effects of structures on antibacterial performance [14]. 121 
The use of drug delivery systems (DDS) has been proposed to overcome important issues in 122 
active pharmaceutical molecules release, such as unfavorable pharmacokinetics and biodistribution 123 
with consequent decrease of side effects. Nanocarriers represent an innovative approach to 124 
overcome these issues [I. Venditti; Engineered gold-based nanomaterials: morphologies and 125 
functionalities in biomedical applications. A mini review; Bioengineering 2019, 6(2), 53; 126 
doi.org/10.3390/bioengineering6020053;]. Moreover, the niosomes systems allow to modulate the 127 
silver concentration loading in a range of interest for the biological applications (0,3-5,0 µg/mL) and 128 
the modulation of release [16]. 129 
In this research study AgNPs were synthetized using 3-mercapto-1-sodium propanesulfonate 130 
(3MPS) to induce hydrophilic behavior improving niosomal entrapment efficiency and reducing 131 
bilayer destabilization. AgNPs were loadea in two different niosomes, Tween 20 and Span 20 loaded 132 
with AgNPs, producing two different systems, namely NioTw20+AgNPs and NioSp20+AgNPs. A 133 
deep physical chemical characterization was carried out to obtain information on hydrophilic 134 
AgNPs and their influence on preparation and characterization of Nio+AgNPs. Moreover, stability 135 
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studies were performed in water, bovine serum and human serum to assess their use in biological 136 
compartment. Hydrophilic and lipophilic probe The release profiles of hydrophilic probe calcein 137 
were performedobtained  in HEPESHEPES and in human serum. manca una frase conclusiva tipo: 138 
Both systems loaded with AgNPs proved to be able to entrap AgNPs, are stable and maintain the 139 
ability to entrap also hydrophilic or lipophilic model molecules so are promising systems for 140 
biotechnological applications. 141 
 142 
 143 
2. Experimental  144 
2.1 Materials and Methods  145 
Silver nitrate (AgNO3, 99.5%, Sigma-Aldrich, St. Louis, MO, USA) and sodium borohydride 146 
(NaBH4, 98%, Sigma-Aldrich, St. Louis, MO, USA), were used for the synthesis of the nanoparticles. 147 
3-mercapto-1propanesulfonic acid sodium salt (C3H7S2O3Na, 3MPS, Sigma Aldrich, 98%) was used 148 
as a capping agent. For all of the solutions, we used deionized water (electrical conductivity less than 149 
1 µΩ/cm at room temperature) obtained from a Millipore Milli-Q water purification system. 150 
HEPESHEPES salt (Sodium 2-(4-(2-hydroxyethyl) piperazin-1-yl) ethanesulfonate), Cholesterol, 151 
Sephadex G75, Pyrene, DPH (1,6-diphenyl-1,3,5-exatriene), Span 20 (sorbitan monolaurate), Tween 152 
20 (polyoxyethylene sorbitan monolaurate), Human/Bovine serum, Calcein and Nile Red were 153 
purchased from Sigma-Aldrich (Milan, Italy). All other products and reagents were of analytical 154 
grade. All of the reagents were purchased from Sigma Aldrich and were used without further 155 
purification. 156 
 157 
2.2 Preparation of AgNPs loaded niosomes 158 
The AgNPs-3MPS synthesis consisted in a wet reduction of silver nitrate to metallic silver by 159 
means of sodium borohydride in presence of 3MPS [Prosposito, P.; Mochi, F.; Ciotta, E.; Casalboni, 160 
M.; De Matteis, F.; Venditti, I.; Fontana, L.; Testa, G.; Fratoddi, I. Hydrophilic silver nanoparticles 161 
with tunable optical properties: Application for the detection of heavy metals in water. Beilstein 162 
journal of nanotechnology 2016, 7, 1654-1661. 163 
Venditti, I.; Testa, G.; Sciubba, F.; Carlini, L.; Porcaro, F.; Meneghini, C.; Mobilio, S.; Battocchio, 164 
C.; Fratoddi, I. Hydrophilic metal nanoparticles functionalized by 2-Diethylaminoethanethiol: a 165 
close look at the metal–ligand interaction and interface chemical structure. The Journal of Physical 166 
Chemistry C 2017, 121, 8002-8013. 167 
Fratoddi, I.; Benassi, L.; Botti, E.; Vaschieri, C.; Venditti, I.; Bessar, H.; Samir, M.A.; Azzoni, P.; 168 
Magnoni, C.; Costanzo, A. Effects of topical methotrexate loaded gold nanoparticle in cutaneous 169 
inflammatory mouse model. Nanomedicine: Nanotechnology, Biology and Medicine 2019.].  170 
Briefly, a solution of AgNO3 in deionized water (0.200 g in 10 mL) was added in a flask with 171 
3MPS water solution (0.830 g in 10 mL) and the mixture was maintained under stirring in argon 172 
atmosphere at room temperature for 10 min. Then NaBH4 water solution (0.220 g in 10 mL) was 173 
finally added dropwise, under vigorous stirring. The reaction mixture was allowed to react for 2 h. 174 
The obtained black product was centrifuged with deionized water tree times (20 min, 5000 rpm) and 175 
then characterized.  176 
Several niosomal formulations by Tween 20 or Span 20 were prepared using AgNPs-3 MPS at 177 
different concentrations. Only results obtained by selected samples in terms of size, ζ-potential, 178 
entrapment efficiency and stability features were reported and discussed.   179 
AgNPs-3 MPS were loaded into Span 20 and Tween 20 niosomes, through a protocol already 180 
used to internalize chemicals [17]. Niosomes were prepared using thin film hydration method [18]. 181 
Span 20 or Tween 20 (15 mM) and cholesterol (15 mM) were dissolved in organic solvent mixture 182 
(chloroform/methanol 3:1 v/v). The solvent was evaporated using rotary evaporator (VV2000, 183 
Heidolph, Schwabach, Germany) to form a thin “film”. The film was hydrated using 5 mL of AgNPs 184 
solution, vortexed and sonicated at 60 °C and 18%/16% amplitude for 5 min using ultrasonic 185 
microprobe (Vibra-Cell VCX-400, Sonics & Materials, Newtown, CT, USA). The unilamellar 186 
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vesicular suspension was purified by gel filtration chromatography using Sephadex G75 (glass 187 
column of 50 × 1.2 cm) with HEPESHEPES buffer as the eluent. The purified vesicles were filtrated, 188 
by using cellulose filters in order to obtain desired dimensions 189 
 190 
2.3 Characterizations 191 
The AgNPs water solution has been characterized by means of UV-VIS spectra of water 192 
suspensions were collected using a Perkin-Elmer Lambda 19 spectrophotometer. The dynamic light 193 
scattering (DLS) measurements on the AgNPs colloidal suspensions (0.200 mg/mL) at T = 25.0 ± 0.2°C 194 
were performed by the Malvern Zetasizer Nano ZS90 instrument (Malvern,UK), as reported in 195 
previous studies [17]. The ζ -potential was calculated from the measured electrophoretic mobility by 196 
means of the Smolukovsky equation [19]. Uv-vis: λmax (nm) 415; DLS: <2RH> 5 ± 2 nm; ζ-potential: -35 197 
± 2 mV. 198 
Mean size, size distribution, and ζ-potential of empty and AgNPs-loaded niosomes were 199 
characterized by using DLS. UV-Visible spectroscopy was employed to evaluate the amount of 200 
AgNPs entrapped in niosomal formulations. 201 
Bilayer characterization has been carried out on empty Span 20 or Tween20 Niosomes and on 202 
AgNPs loaded ones, employing DPH and pyrene (lipophilic probes) that provided different bilayer 203 
information (fluidity, microviscosity, and polarity)  204 
Span 20/Tween 20 (15 mM), cholesterol (15 mM), and DPH solution (2 × 10−4 M) were codissolved in 205 
chloroform/methanol, which was removed using rotatory evaporator (VV2000, Heidolph, 206 
Schwabach, Germany), hydrated with HEPESHEPES buffer or AgNPs solution (0,5 mg/ml), with the 207 
same preparation methods above mentioned. Cellulose filter of 450 nm cut off was used to purify the 208 
DPH-niosomal formulations. Fluorescent measurements were performed (λ = 350–425 nm) using 209 
luminescence spectrometer (LS5013, PerkinElmer) in order to obtain Florescence Anisotropy. The 210 
florescence anisotropy (r) was determined by using Equation (1) [20-22].  211 
 212 
𝐴 =  
𝐼𝑣𝑣 −𝐼𝑣ℎ  𝑥 𝐺
𝐼𝑣𝑣 + 2𝐼𝑣ℎ 𝑥 𝐺
   (1) 213 
 214 
where IVV, IVH, IHV and IHH are fluorescent intensities, and subscript V (vertical) and H 215 
(horizontal) represent the orientation of polarized light. G factor is ratio of sensitivity of detection 216 
system for vertically and horizontally polarized light. 217 
 218 
Pyrene loaded niosomes were prepared by adding the probe (4 mM) to niosomes (Nio) 219 
components in order to obtain empty and Nio-AgNPs following the same preparation method as 220 
above. Pyrene is a florescence probe, whose monomer exhibited a spectrum characterized with five 221 
emission peaks (from I1 to I5) and excimer has only one peak (IE). The monomer and the excimer 222 
have different fluorescence signals, and the ratio between the several fluorescence intensities is 223 
directly related to the probe distribution in the bilayer. In particular, the ratio I1/I3, corresponding to 224 
the first and third vibration bands in the pyrene spectrum, is related to the polarity of the probe 225 
environment. Pyrene can form intramolecular excimer based on the viscosity of the probe 226 
microenvironment [23], and it is estimated with the ratio IE/I3, where IE is the excimer intensity. The 227 
fluorescence signals emitted by pyrene loaded niosome suspension was scanned (λ = 350–550 nm) 228 
using luminescence spectrometer (LS5013, PerkinElmer) and intensities of excimer florescence (IE), 229 
first (I1), and third (I3) peak were recorded [24].  230 
Atomic force microscopy (AFM) study of the morphology of the niosomes has been performed using 231 
a standard AFM setup (Dimension Icon, Bruker Inc.) equipped with Si cantilevers suitable for 232 
tapping mode imaging. Samples have been prepared by depositing a droplet of solution on a clean 233 
monocrystalline Si surface and waiting until partial dehydration. AFM imaging has been performed 234 
in air and at room conditions. 235 
SAXS experiments were performed at ID02 high-brilliance beamline at the ESRF (Grenoble, France). 236 
The measured SAXS profiles report the scattered radiation intensity as a function of the momentum 237 
transfer, q = (4π/λ)sin(θ/2), where θ is the scattering angle and λ  the x-ray wavelength (0.1 nm). 238 
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Analysis was carried out to obtain information on dimension, homogeneity, shape of the particles in 239 
solution. The form factors of niosomes have been reconstructed as uni-lamellar or multi-lamellar 240 
closed bilayers. Details are reported in the Supporting information. 241 
Biological studies were also carried out in the presence of Bovine or Human serum to evaluate the in 242 
vitro stability. Mixtures of empty and AgNPs loaded Nio and 45% of Bovine or Human serum, were 243 
prepared and incubated at 37 °C. Analyses were performed at different time intervals (0, 0.5, 1, 2, 244 
and 3 h) by DLS (to evaluate variations of particle size and ζ-potential [25].  245 
Stability studies up to 90 days at different temperatures, room temperature (RT) and 4°C, were 246 
carried out by DLS, to asses dimension and ζ-potential of empty niosomes and Nio -AgNPs [25]. 247 
Release studies were carried out following the release calcein from empty niosomes and Nio- 248 
-AgNPs using Fluorimetric apparatus. 249 
The hydrophilic probe (calcein 10-2M) was added to formulation during film hydration and the 250 
excess of calcein was purified with the same technique above mentioned [25]. 251 
In vitro release experiments were performed at 37°C, defined volume of vesicle dispersions was 252 
included in dialysis sacs (cut-off 8.000) with a fixed diffusing area (5.5 cm2) adding to niosomal 253 
formulation 45% of human serum or HepesHEPES (in order to maintain the same probe 254 
concentration). The probe concentration was detected in the outer solution at fixed time intervals (0, 255 
1, 2, 3, 4, 5, 6, 7, 8 and 24 h) by means of the Fluorometric apparatus taking into account the dilution 256 
factor.  257 
Results and discussion 258 
AgNPs were functionalized by 3MPS to induce high hydrophilicity and to control the shape 259 
and dimension in the range of 2-5 nm, as already report [F. Mochi, L. Burratti, I. Fratoddi, I. Venditti, 260 
C. Battocchio, L. Carlini, G. Iucci, M. Casalboni, F. De Matteis, S. Casciardi, S. Nappini, I. Pis, P. 261 
Prosposito; Interaction of colloidal silver nanoparticles with Co2+ and Ni2+ in water for sensing 262 
application; Nanomaterials 8 (2018) 488; doi:10.3390/nano8070488www 263 
Corsi, P.; Venditti, I.; Battocchio, C.; Meneghini, C.; Bruni, F.; Prosposito, P.; Mochi, F.; Capone, 264 
B. Designing an Optimal Ion Adsorber at the Nanoscale: The Unusual Nucleation of AgNP/Co2+–265 
Ni2+ Binary Mixtures. The Journal of Physical Chemistry C 2019, 123, 3855-3860]. In fact, the 266 
hydrophilicity is a crucial feature to obtain the insertion in the aqueous core of the niosomes. Even 267 
the small dimensions are a key parameter to ensure the inclusion and above all the stability of the 268 
final hybrid system, as also reported in the literature [Yusuf 2017]. The AgNPs were loaded into 269 
niosomes by adding nanoparticles during the typical preparation protocol of niosomes, as 270 
schematized in Figure 1. 271 
 272 
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Figure 1  Preparation scheme of Nio -–AgNPs preparation. 306 
 307 
 308 
According to characterization results obtained, the best samples selected were Tween 20/Span 20 309 
niosomes hydrated with AgNPs at the 0,5 mg/ml concentration. 310 
+
Tw20/Span 20  surfactant + Chol+
organic mixture
+ rotary evaporator 
Niosomal thin “film”
+AgNPs solution
Nio+ AgNPs
Niosomes AgNPs-Niosomes
+
Tw20/Span 20  surfactant + Chol+
organic mixture
+ rotary evaporator 
Niosomal thin “film”
+AgNPs solution
Nio+ AgNPs
Niosomes AgNPs-Niosomes
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The first comparison between empty niosomes and Nio -AgNPs was done by analyzing 311 
hydrodynamic diameter, ζ-potential and PDI (Polydispersity index) by DLS. Results are shown in 312 
table 1. 313 
In both niosomal formulations, by Tween 20 or Span 20, all the parameters analysed by DLS are 314 
preserved after the addition of AgNPs. The empty samples show differences in dimensions, due to 315 
the different internal structures determined by the different surfactant employed for niosomal 316 
preparation. In particular Span 20 niosomes, as expected [26] are bigger than Tween 20 ones and 317 
show more negative ζ-potential. 318 
 319 
 320 
Sample Hydrodynamic diameter 
(nm) ± SD 
ζ-potential (mV) ±SD PDI ± SD 
NioTw20 136.1 ± 2.0 -32.8 ± 0.3 0.38 ± 0.01  
NioTw20+AgNPs 140.3 ± 3.9 -33.1 ± 1.4 0.40 ± 0.01 
NioSp20 230.2 ± 5.9 -42.7 ± 2.3 0.35 ± 0.01 
NioSp20+AgNPs 251.7 ± 6.0 -42.9 ± 1.2 0.40 ± 0.01 
 321 
Table 1. Hydrodynamic diameter, ζ-potential and PDI of different niosomal formulations.  322 
 323 
The entrapment efficiency of AgNPs in vesicular systems, was evaluated by means of the 324 
calibration curve (see SI-Fig.2) and results are reported in Table 2. 325 
 326 
 327 
 328 
Samples ID 
Entrapment efficiency 
(mg/mL) 
NioTw20 + AgNPs <1 % 
NioSp20 + AgNPs 4 % 
 329 
Table 2. The trapping efficiency of AgNPs in niosomes 330 
 331 
The data obtained indicate that entrapment efficiency for the two systems is not the same; better 332 
for Span 20 than Tw20 niosomes, probably related to different internal structure and or capacity 333 
(aqueous volume available to host AgNPs). Moreover, these values allow to assemble systems with a 334 
silver concentration in the range of interest for biological applications (0,3-5,0 µg/mL) as reported in 335 
literature [16]. Results obtained by bilayer characterization studies (table 3), show no variation in the 336 
evaluated bilayer properties (table 3), thus demonstrating that no interactions occur between 337 
niosomal double layer and AgNPs, that probably will be located inside aqueous compartments. 338 
 339 
 340 
Sample Fluidity (Anisotropy) Microviscosity (IE/I3) Polarity (I1/I3) 
NioTw20  0.10 0.90 0.90 
NioTw20+AgNPs 0.11 0.90 0.90 
NioSp20 0.10 1.01 0.94 
NioSp20+AgNPs 0.11 1.03 0.90 
 341 
Table 3: Bilayer Characterization Results of Nio and Nio-AgNPs  342 
 343 
 344 
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Morphological studies were performed on empty niosomes and Nio -AgNPs . Representative 345 
AFM images of the samples are shown in Fig. 2. The morphological characterization indicates that 346 
niosomes have regular spherical shape. Probably due to the intrinsic limitations related to sample 347 
preparation, the size of niosomes seems highly dispersed, according to PDI values by DLS analyses, 348 
the bigger particles being probably the results of agglomeration of individual niosomes. 349 
 350 
 351 
 352 
Figure 2: AFM images related to: NioTw20 (Fig 2a), NioTw20+AgNPs (Fig. 2 b), NioSp20 (Fig.2 c) 353 
and NioSp20+AgNPs (Fig. 2 d). 354 
 355 
In deposited sample, large amorphous particles are visible, likely resulting from coalescence of 356 
several vesicles on the substrate surface as well as the possible partial dehydration make the vesicles 357 
lose their original spherical shape. By a visual inspection, Tween–based niosomes, i.e., NioTw20 (Fig 358 
2a) and NioTw20+AgNPs (Fig. 2 b), are smaller than the Span-based ones, i.e., NioSp20 (Fig.2 c) and 359 
NioSp20+AgNPs (Fig. 2 d), in qualitative agreement with the measured hydrodynamic diameter 360 
reported in Table1. Conversely, the effect on the size of the presence of AgNPs cannot be appreciated 361 
in both the Tween and Span based formulation, as expected considering the relatively small 362 
variations evaluated by DLS and the dispersion of the size in AFM samples.  363 
In order to characterize the local structure of niosomes, SAXS measurements whave been were 364 
performed on Tween20 and Span20 niosomes empty and loaded with AgNPs. 365 
In Figure 3 the intensity spectra are reported for Tween20 based nanoparticles (panel A) and for 366 
Span20 based nanoparticles (panel B) in a wide q range (0.014 nm-1 ≤ q ≤ 6 nm-1 ), corresponding to 367 
distances from 150 nm to the nm. Differences in the intensity profiles are clearly visible for the two 368 
systems in all regions of the spectra. Besides the feature of the form factor of the particles in solution 369 
a small diffraction peak at 1.84 nm-1, corresponding to a characteristic distance of 3.41 nm, is well 370 
known, and stems for the presence of cholesterol crystallites in surfactants/cholesterol mixtures [27]. 371 
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Crystallites could be either excluded from the bilayers, in peripheral contact, for example, or 372 
included in the bilayers, as segregated structures. 373 
 374 
 375 
 376 
Figure 3 SAXS spectra of Tween 20 and Span 20 based niosomes. Panel A. Tween 20 based empty 377 
niosomes (blue diamonds) and AgNPs-Nio- AgNPs (magenta dots). Fitting curves have been 378 
obtained by modelling the particle as an internal solvent core surrounded by a surfactant closed 379 
bilayer (for details see Supporting Information……. ). Panel B. Span 20 based empty niosomes (green 380 
diamonds) and AgNPs-Nio - AgNPs (orange dots).  381 
 382 
Tween20 based particles display a niosomes shape, characterized by a local bilayer structure 383 
with thickness of about 6 nm, being the hydrophobic core of 2.5 nm and the two hydrophilic layers 384 
of 1.6 nm and of 2 nm, respectively. Moreover, the absence of peaks due to multilamellar 385 
organization, reveals that the adopted structure is unilamellar.  386 
In the presence of AgNPs Tween 20 niosomes keep a local unilamellar structure, with unaffected 387 
structural features. On the other hand, in the low-q region of the spectrum, the scattered intensity 388 
increases by one order of magnitude. The form factor of the unilamellar closed particles can be 389 
modelled replacing the internal water with a higher electron density solvent, confirming the 390 
presence of AgNPs entrapped inside the aqueous core of the niosomes. 391 
 Span 20 based aggregates display the characteristic features of closed lamellar-type particles. 392 
Nevertheless, the local structure of Span 20 based niosomes is quite different from the Tween 20 393 
based one. A broad intensity peak is clearly visible at q = 1.6 nm-1, together with a very broad left 394 
shoulder. The position of the peak corresponds to a characteristic distance d = 3.9 nm, compatible 395 
with twice the length of a Span 20 (sorbitan monolaurate) molecule. Results indicate that Span 20 396 
niosomes are multilamellar closed particles, with a water core surrounded by a peculiar layered 397 
shell: several adjacent concentric bilayers are in close contact, heads to heads, without any water 398 
penetration. The scattered intensity profile of Span20-based loaded niosomes, reported in Figure 3 399 
(panel B), presents a pronounced increase in the low-q region, sign of the presence of AgNps 400 
enclosed in the internal aqueous core of the niosomes. The increase is definitely higher than the one 401 
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observed in Tween 20 based AgNPs-Nio-AgNPs, suggesting that Span 20 is more efficient in 402 
entrapping metallic NPs. On the local scale, two additional peaks at q = 1 nm-1 and q = 2 nm-1 are 403 
visible, revealing a swollen multilamellar structure with characteristic distance d = 6 nm, coexisting 404 
with the tight one at d = 3.9 nm. The 6 nm distance is typical for lipid multilamellar structures and 405 
also found in Tween®20-derivatives/cholesterol niosomes [27]. The presence of AgNPs induces 406 
partial disjunction of adjacent bilayers with an increased water penetration. 407 
Stability studies of NioTw20/NioTw20+AgNPs and NioSp20/NioSp20+AgNPs were performed 408 
in bovine serum and human serum to compare their behavior in biological compartment, as shown 409 
in Figure 4. Empty niosomes are stable both at room temperature and at 4°C, while Nio-AgNPs 410 
Nio+AgNPs showed a different behavior in terms of dimensional increase at RT conditions, not 411 
confirmed at 4°C storage temperature. Colloidal stability at 4°C is higher because of reduced 412 
collision events of the dispersed particles and hence coalescent phenomena. 413 
 414 
 415 
 416 
Figure 4. Stability studies of empty niosomes and Nio –AgNPs at room temperature and 4°C. 417 
 418 
The effect of the serum (human and bovine) is another important element to evaluate in order to 419 
define the interaction between vesicles and fluids. Experiments were performed at 37° C evaluating 420 
the size and z-potential (data not shown) variations by DLS analysis up to 3h (Figure 5). During the 421 
time interval analyzed, the same trend is observed for all vesicles. Vesicles in 45% bovine serum do 422 
not show a dimensional increase, while in 45% human serum the trend is different. The different 423 
protein composition of human serum is the reason of the attractive interaction between negatively 424 
charged niosomal surface and proteins. These interactions are strong enough to observe the same 425 
populations for the three hours.  426 
 427 
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 428 
 429 
Figure 5: Niosomal biological stability at 37°C in different media. A) NioTw20/AgNPs in bovine and 430 
human serum; B) NioSp20/AgNPs in bovine and human serum.  431 
 432 
In order to confirm the ability of Nio to release lipophilic and hydrophilic probes, also in 433 
presence of AgNPs, calcein and Nile Red release studies were carried out. Qui andrebbe messa frase 434 
che spiega perchè è stato fatto questo esperimento con calceina, tanto per rendere più fluido il 435 
discorso. 436 
In figures 6 and 7 release profiles of the hydrophilic probe calcein and Nile Red. are reported a 437 
che temperature questo esperimento?. In each experiment, the calcein release data from empty 438 
niosomes and NioTw20 AgNPs were compared in order to evaluate the influence of the silver 439 
nanoparticles, entrapped in the same compartment, on the hydrophilic probe release. The calcein 440 
entrapment in both samples was comparable. Experiments were carried  out at 37°C both in 441 
HepesHEPES and human serum. The results obtained in human serum are not reported because the 442 
calcein release was not significant (20%) probably due to coating and masking effects of serum, 443 
which makes it difficult to quantify the calcein release in the external medium. In HepesHEPES 444 
buffer, the presence of AgNPs influences the release profile of calcein only in NioTw20 formulation. 445 
As demonstrated by SAXS analyses, only a double layer is present, so more susceptible to silver 446 
nanoparticles destabilization. Calcein release by this sample is around 65% in 24 hours, respect to 447 
30% by NioSp20/AgNPs, where the presence of different bilayer can make more difficult calcein 448 
release. 449 
 450 
   451 
 452 
Figure 6: Calcein Rrelease studies in HepesHEPES buffer at 37°C temperature ??? from: A) 453 
NioTw20/AgNPs calcein release profiles in Hepes buffer; B) NioSp20/AgNPs calcein release 454 
profiles in Hepes buffer. 455 
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 456 
 457 
On the contrary, in both samples Nile Red release profiles, obtained in HEPESHEPES at 37°C 458 
….a che temperature??  (figure 7 A and B) are comparable, because of the lipophilic nature of the 459 
probe, as shown in figure 7. 460 
The number of bilayers to cross is the limiting step for hydrophilic probe release, while it is not 461 
for lipophilic probe, thatprobe that is located in the bilayer and will be barely released for the poor 462 
affinity with the aqueous external medium. 463 
 464 
 465 
 466 
Figure 7: Nile Red release studies studies in HepesHEPES buffer at temperature ???37°C A) 467 
NioTw20/AgNPs in Hepes buffer; B) NioSp20/AgNPs. in Hepes buffer. 468 
 469 
The morphological structure of the two different niosomal formulations and the presence or not 470 
AgNPS, could to influence the release profiles of the two probes. Frase finale??? 471 
 472 
 473 
4. Conclusions potete scrivere voi conclusioni? 474 
This study confirms the possibility of preparing niosomal vesicles by Tween 20, or Span 20 475 
loaded with AgNPs which, as expected, enterare located inside the aqueous compartment of the two 476 
systems, as confirmed by the SAXS data, that also allow ; these have allowed to highlight the 477 
different structure of the double layer of the studied samples. Our experiments make us think 478 
thatshow that the samples prepared with the surfactant 479 
 Span 20 trapped particles more efficiently than Tween 20, reaching the concentration at which 480 
metallic nanoparticle effects are observed on in vitro cell cultures, as demonstrated by studies 481 
reported in the literature [1635]; in vesicles based on Tween 20 the concentration reached is lower 482 
but presumably such as to fall within the efficacy range of the nanoparticles. 483 
The systems we study arecould be important in increasing skin permeationfor biological 484 
applications. ; this data, together with the ability to transport silver nanoparticles with antibacterial 485 
activity, emerged from the thesis work, makes them an innovative drug delivery system for the 486 
treatment of skin lesions and chronic skin diseases. 487 
The studies carried out during my thesis work have revealed a different behavior of the samples 488 
prepared on the basis of their surfactant composition, the loading with the silver nanoparticles, and 489 
according to the medium in which they were placed. 490 
In particular, it was found that the formation of the niosomal vesicles also occurs in the presence of 491 
the AgNPS, which, as expected, enter the aqueous compartment of the system, as confirmed by the 492 
SAXS data; these have allowed to highlight the different structure of the double layer of the studied 493 
samples. Our experiments make us think that the samples prepared with the surfactant 494 
Span 20 trapped particles more efficiently than Tween 20, reaching the concentration at which 495 
metallic nanoparticle effects are observed on in vitro cell cultures, as demonstrated by studies 496 
reported in the literature [35]; in vesicles based on Tween 20 the concentration reached is lower but presumably such as to fall within the efficacy range of the nanoparticles. 497 
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The systems we study are important in increasing skin permeation; this data, together with the abilty to transport silver nanoparticles with antibacterial activity, emerged from the thesi work, makes them an innovative drug delivery system for the treatment of skin lesions and chronic skin diseases. 498 
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